Plain-English translation of NCT04908644 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ulcerative Colitis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a small pilot study testing whether MS-20, a fermented soybean extract, can help improve ulcerative colitis symptoms when taken alongside your regular UC medications. Researchers want to see how this medication affects your gut bacteria, your UC symptoms, and your overall health over 12 weeks. Half of participants will receive the active treatment, and half will receive a placebo (inactive treatment).
Ulcerative colitis causes ongoing inflammation and discomfort in the colon, and current treatments don't work equally well for everyone. This trial is exploring whether this medication might help reduce severity and improve quality of life by supporting healthier gut bacteria.
You will take 8 milliliters of either the active medication or a placebo twice daily (morning and evening) for 12 weeks. You'll have study visits where researchers check your UC symptoms, take blood samples, and ask you to collect and deliver stool samples from home. The researchers will track changes in your gut bacteria, your UC symptom scores, and any side effects throughout the trial.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Taiwan